You are here: Industry Insights > Hereditary

News List

NICE recommends Takeda’s Takhzyro in hereditary angioedema pharmaceutical-technology
September 25, 2019
The UK’s National Institute for Health and Clinical Excellence (NICE) has recommended the use of subcutaneous injection of Takeda’s Takhzyro (lanadelumab) to prevent recurrent attacks ...
Santhera licenses Leber’s hereditary optic neuropathy drug to Chiesi pharmaceutical-technology
August 06, 2019
Santhera Pharmaceuticals has licensed a drug called Raxone, indicated for the treatment of Leber’s hereditary optic neuropathy (LHON), to Chiesi Farmaceutici (Chiesi Group).
Blood Banks Could Help Screen for Hereditary High Cholesterol drugs
May 23, 2019
Blood Banks Could Help Screen for Hereditary High Cholesterol.
Gene variant activity is notably variable between tissues worldpharmanews
August 18, 2017
New study found that both genetic and epigenetic differences between the maternal and paternal allele contributed to the observed tissue-specific activity patterns, uncovering the first complete allelome.